Avience Biomedicals Ltd vs Gpt Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Avience Biomedicals Ltd is ₹ 253.15 as of 30 Oct 15:30 . The P/E Ratio of Avience Biomedicals Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of GPT Healthcare Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 5 years The Market Cap of Avience Biomedicals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of GPT Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 5 years The revenue of Avience Biomedicals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of GPT Healthcare Ltd for the Jun '26 is ₹ 128.23 crore as compare to the Mar '26 revenue of ₹ 128 crore. This represent the growth of 0.18% The ebitda of Avience Biomedicals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of GPT Healthcare Ltd for the Jun '26 is ₹ 26.21 crore as compare to the Mar '26 ebitda of ₹ 25 crore. This represent the growth of 4.84% The net profit of Avience Biomedicals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of GPT Healthcare Ltd changed from ₹ 9.96 crore to ₹ 12.73 crore over 9 quarters. This represents a CAGR of 11.52% The Dividend Payout of Avience Biomedicals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of GPT Healthcare Ltd changed from 46.79 % on March 2021 to 48.58 % on March 2026 . This represents a CAGR of 0.63% over 6 years .

About Avience Biomedicals Ltd

Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

About GPT Healthcare Ltd

GPT Healthcare Limited was formerly established as 'Jibansatya Printing House Private Limited' on August 17, 1989 at Kolkata, West Bengal.
The name of Company was changed to 'GPT Healthcare Private Limited' by the Registrar of Companies on March 31, 2005.
Thereafter, Company converted to a Public Company and the name was changed to 'GPT Healthcare Limited'.
Consequent upon change in name to a Limited Company, a fresh Certificate of Incorporation was issued by the RoC on September 15, 2021. The principal activities of the Company include operation of multidisciplinary private hospitals and pharmacies.
The Company is having four Multispecialty hospitals.

FAQs for the comparison of Avience Biomedicals Ltd and GPT Healthcare Ltd

Which company has a larger market capitalization, Avience Biomedicals Ltd or GPT Healthcare Ltd?

Market cap of Avience Biomedicals Ltd is 138 Cr while Market cap of GPT Healthcare Ltd is 1,088 Cr

What are the key factors driving the stock performance of Avience Biomedicals Ltd and GPT Healthcare Ltd?

The stock performance of Avience Biomedicals Ltd and GPT Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Avience Biomedicals Ltd and GPT Healthcare Ltd?

As of October 31, 2026, the Avience Biomedicals Ltd stock price is INR ₹253.15. On the other hand, GPT Healthcare Ltd stock price is INR ₹132.7.

How do dividend payouts of Avience Biomedicals Ltd and GPT Healthcare Ltd compare?

To compare the dividend payouts of Avience Biomedicals Ltd and GPT Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.